Prestroke Statins Improve Prognosis of Atrial Fibrillation-Associated Stroke through Increasing Suppressor of Cytokine Signaling-3 Levels
Conclusion: Our data suggested that the prestroke use of statins improved the clinical outcomes in AIS patients with AF by upregulating the level of SOCS-3 and reducing the plasma MMP-9 level.Eur Neurol
Source: European Neurology - Category: Neurology Source Type: research
More News: Atrial Fibrillation | Brain | Cholesterol | Disability | Electrocardiogram | Ischemic Stroke | Neurology | Statin Therapy | Stroke | Study